Advertise alongside our Nature Technology Feature on vaccines in the COVID-19 era

Update: this Technology Feature has been published. View opportunities to advertise alongside upcoming Technology Features.

Don’t miss this opportunity to target over 50,000 Nature subscribers

Introducing the Technology Features

These editorially-independent features, published in the Nature and Nature Methods print journals and online on, spotlight scientists, the technology, and the methods they choose – their views of what works and what does not – providing key information that scientists globally can implement in their own labs.

25 Technology Features are being published in Nature and Nature Methods throughout 2020, and in July, Nature is publishing its next Technology Feature on vaccines.

‘Immunology: Vaccine development in the COVID-19 era’

Vaccines are based on a simple premise: by injecting components of a pathogen before an individual encounters it in the wild, doctors can train the immune system to target and eliminate that pathogen before it can cause disease. For centuries, vaccine-makers relied on weakened or killed versions of the pathogen they wished to thwart. But that strategy hasn’t worked for some ongoing scourges, including HIV, malaria, tuberculosis and dengue fever. And when it comes to COVID-19, the clock is ticking. But today’s vaccinologists are working smarter and faster, developing vaccines using nucleic acids and peptides, and incorporating protein structure and computational methods into their work.

The Technology Feature will cover:

  • The challenges of rapid vaccine development
  • New approaches to vaccine design
  • Accelerating testing with systems immunology

Publication & Publication Date: Nature, July 23, 2020
Ad Booking Deadline: July 8, 2020
Ad Materials Due: July 10, 2020

Contact us to advertise – hurry, ends July 8th!

Advertise in print and online alongside our Technology Feature to deliver your message to a targeted immunology audience and place your brand right alongside Nature Research’s influential content. (Please note that our Technology Features are editorially-independent and not supported by any sponsor).

To amplify your message further across the Springer Nature network, why not target our wider immunology audience across all our journals and articles. We publish 59 relevant journals, with websites generating 1.3 million average monthly pageviews.

Contact us before July 8th » simply include ‘Technology Feature’ in your message


Interested in our upcoming Technology Features? View the Nature and Nature Methods 2020 calendars.

Plus, check out the Technology Features that have already been published.

See all posts